SUN Pharmaceutical Industries Limited Ciprofloxacin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Ciprofloxacin Export Records India — #2 Exporter, 407 Shipments, $20.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ciprofloxacin

India Pharmaceutical Trade Intelligence

$301.1M1,001 Suppliers180 CountriesHS 30042013

ExportsIndia → UNITED STATES42.3%India → RUSSIA7.1%

ImportsUNITED STATES → India$518.1K ITALY → India$94.7K

#1 Buyer: DR REDDYS

SUN Pharmaceutical Industries Limited — Ciprofloxacin Exporter #2 | $21.4M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Ciprofloxacin Exporter Profile

Indian Pharmaceutical Exporter · #2 for Ciprofloxacin · $21.4M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #2 Indian exporter of Ciprofloxacin with $21.4M in export value and 407 verified shipments. SUN Pharmaceutical Industries Limited holds a 6.8% market share in Ciprofloxacin exports across 19 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Ciprofloxacin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Ciprofloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Ciprofloxacin?

Country	Value	Shipments	Share
RUSSIA	$4.2M	108	36.9%
UNITED STATES	$2.3M	46	20.0%
BELGIUM	$2.0M	116	17.4%
CANADA	$862.0K	25	7.6%

Who Are the Top Buyers of Ciprofloxacin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
AO RANBAXY	RUSSIA	$3.0M	84
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$1.9M	111
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$1.3M	26
AO "RANBAXY"	RUSSIA	$772.7K	16
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$650.0K	13
TARO PHARMACEUTICALS INC.,	CANADA	$402.0K	9
M S AO RANBAXY	RUSSIA	$400.0K	8
TARO PHARMACEUTICALS INC	CANADA	$300.0K	6
SUN PHARMA ANZ PTY LTD.	AUSTRALIA	$291.0K	20
RANBAXY PHARMACEUTICALS PTY LTD.,	SOUTH AFRICA	$182.2K	22

SUN Pharmaceutical Industries Limited supplies Ciprofloxacin to 60 buyers globally. The largest buyer is AO RANBAXY (RUSSIA), followed by YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ciprofloxacin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (	$550.0K	11
CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA (BATCH NO AS PER INVOICE)	$373.4K	8
CIPROFLOXACIN 0.3% AND DEXAMETHASONE	$250.0K	5
APO-CIPROFLOXACIN TAB 500mg. EACH FILM C	$174.5K	7
CIPROFLOXACIN TABLETS 500MG ( CIFRAN TAB	$150.0K	3
CIFRAN CT TAB PACK:10S STRIP BATCH:DFE8281A, DFE8359A EACH TAB CONTS. CIPROFLOXACIN HCL EQ TO CIPROFLOXACIN 500MG AND TIPCS	$150.0K	3
CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP (FOR CANADA)	$150.0K	3
CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA PACK : 01*01 (BATCH NO AS PER INVO	$150.0K	3
CIFRAN CT TAB PACK : 10S STRIP BATCH : DFE8431A, DFE8432A EACH TAB CONTS CIPROFLOXACIN HCL EQ TO CIPROFLOXACIN 500MG ANPCS	$150.0K	3
CIFRAN CT TAB PACK : 10S STRIP BATCH : DFE8317A, DFE8430A, DFF0019A, DFF0020A EACH TAB CONTS CIPROFLOXACIN HCL EQ TO CIPPCS	$150.0K	3

SUN Pharmaceutical Industries Limited exports 230 distinct Ciprofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROFLOXACIN (0.3%) AND DEXAMETHASONE ( with 11 shipments worth $550.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Ciprofloxacin Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$20.4M	407	19	$50.0K
5	AUROBINDO PHARMA LTD	$11.4M	250	13	$45.4K
6	SENTISS PHARMA PRIVATE LIMITED	$8.8M	177	7	$50.0K

SUN Pharmaceutical Industries Limited ranks #2 among 1001 Indian Ciprofloxacin exporters. Average shipment value of $50.0K compared to the market average of $74.5K. The closest competitors by value are AUROBINDO PHARMA LTD and SENTISS PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Ciprofloxacin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,828	12.9%
SAHAR AIR	1,481	10.5%
NHAVA SHEVA SEA (INNSA1)	1,254	8.9%
DELHI AIR CARGO ACC (INDEL4)	969	6.8%
JNPT/ NHAVA SHEVA SEA	766	5.4%
DELHI AIR	722	5.1%
JNPT	595	4.2%
Bombay Air	375	2.7%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Ciprofloxacin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ciprofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 430 individual customs records matching SUN Pharmaceutical Industries Limited exporting Ciprofloxacin, covering 230 formulations to 22 countries via 60 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 180+ countries, 3,081+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ciprofloxacin

Ciprofloxacin

SUN Pharmaceutical Industries Limited — Ciprofloxacin Exporter Profile

SUN Pharmaceutical Industries Limited — Ciprofloxacin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Ciprofloxacin?

Who Are the Top Buyers of Ciprofloxacin from SUN Pharmaceutical Industries Limited?

What Is India's Total Ciprofloxacin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Ciprofloxacin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Ciprofloxacin Exporters?

What Ciprofloxacin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Ciprofloxacin to Key Markets

United States — FDA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Ciprofloxacin Exporters?

Which Indian Ports Ship Ciprofloxacin Exports?

What Other Antibiotics Products Does SUN Pharmaceutical Industries Limited Export?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Ciprofloxacin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ciprofloxacin Export Data from SUN Pharmaceutical Industries Limited

Ciprofloxacin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source